Xbrane Biopharma AB banner

Xbrane Biopharma AB
STO:XBRANE

Watchlist Manager
Xbrane Biopharma AB Logo
Xbrane Biopharma AB
STO:XBRANE
Watchlist
Price: 8.3 SEK -1.19% Market Closed
Market Cap: kr171.1m

Dividends

Xbrane Biopharma AB
does not pay dividends

Shareholder Yield

Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Peers Comparison
Shareholder Yield

Company Total Yield Dividend Yield Buyback Yield Debt Paydown Yield

Buybacks

Buyback Yield
Xbrane Biopharma AB

Period
3Y
5Y
10Y
15Y
30Y
Yield Statistics, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Company Buyback Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Debt Paydown

Debt Paydown Yield
Xbrane Biopharma AB

Period
3Y
5Y
10Y
15Y
30Y
Yield Statistics, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Company Debt Paydown Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Price Appreciation

XBRANE Price
Xbrane Biopharma AB

Annual Price Range
8.3
52w Low
5.656
52w High
36.775
Price Metrics
Average Annual Return -47.09%
Standard Deviation of Annual Returns 47.52%
Max Drawdown -100%
Shares Statistics
Market Capitalization 171m SEK
Shares Outstanding 20 610 000
Percentage of Shares Shorted
N/A

XBRANE Return Decomposition
Main factors of price return

Stock Splits

XBRANE's latest stock split occurred on Oct 17, 2025

The company executed a 1-for-125 stock split, meaning that for every 125 shares held, investors received 1 new share.

Before the split, XBRANE traded at 31.15 per share. Afterward, the share price was about 23.3.

The adjusted shares began trading on Oct 17, 2025. This was the only stock split in XBRANE's history.

Pre-Split Price
31.15 31.15
Post-Split Price
23.3
Before
After
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett